Please Enable Cookies

www.cablinginstall.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iradimed Corp (NQ: IRMD )

42.82 -0.08 (-0.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 32,675
Open 43.07
Bid (Size) 41.14 (1)
Ask (Size) 44.60 (1)
Prev. Close 42.90
Today's Range 42.60 - 43.29
52wk Range 36.44 - 50.85
Shares Outstanding 12,664,185
Dividend Yield 2.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
Trading to commence effective on the market open June 14, 2024 
From iRadimed Corporation
Via GlobeNewswire
IRMD Stock Earnings: iRadimed Beats EPS, Beats Revenue for Q1 2024
IRMD stock results show that iRadimed beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-9.45%
-9.45%
1 Month
+1.04%
+1.04%
3 Month
-0.30%
-0.30%
6 Month
-8.39%
-8.39%
1 Year
-12.95%
-12.95%

More News

Read More
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
From iRadimed Corporation
Via GlobeNewswire
Earnings Scheduled For February 8, 2024
Via Benzinga
iRadimed's Earnings Outlook
Via Benzinga
Wednesday Is Your Last Chance To Buy iRadimed Before The Dividend Payout
Via Benzinga
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
From iRadimed Corporation
Via GlobeNewswire
iRadimed's Earnings: A Preview
Via Benzinga
Should you consider NASDAQ:IRMD for quality investing?
Via Chartmill
iRadimed: Q1 Earnings Insights
Via Benzinga
Bruker Stock Rising, Near Buy Point; Gets Rating Upgrade
Via Investor's Business Daily
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
From iRadimed Corporation
Via GlobeNewswire
Caleres, Cloudflare And 2 Other Stocks Insiders Are Selling
Via Benzinga
Earnings Scheduled For November 3, 2023
Via Benzinga
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
From iRadimed Corporation
Via GlobeNewswire
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
From iRadimed Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.